[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786-432-9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 45, "title": "CEO & Chairman", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 626193, "exercisedValue": 0, "unexercisedValue": 113700}, {"maxAge": 1, "name": "Mr. Alan  Weichselbaum CPA, M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.65, "open": 1.65, "dayLow": 1.53, "dayHigh": 1.65, "regularMarketPreviousClose": 1.65, "regularMarketOpen": 1.65, "regularMarketDayLow": 1.53, "regularMarketDayHigh": 1.65, "payoutRatio": 0.0, "forwardPE": -3.142857, "volume": 343216, "regularMarketVolume": 343216, "averageVolume": 1477461, "averageVolume10days": 663110, "averageDailyVolume10Day": 663110, "bid": 1.51, "ask": 1.58, "bidSize": 2, "askSize": 1, "marketCap": 28444416, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 2.7, "fiftyDayAverage": 1.3962, "twoHundredDayAverage": 1.243515, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 24849934, "profitMargins": 0.0, "floatShares": 13098326, "sharesOutstanding": 18470400, "sharesShort": 1198426, "sharesShortPriorMonth": 153955, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.064899996, "heldPercentInsiders": 0.19677, "heldPercentInstitutions": 0.058080003, "shortRatio": 0.38, "shortPercentOfFloat": 0.081999995, "impliedSharesOutstanding": 18470400, "bookValue": 0.077, "priceToBook": 20.0, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -7918667, "trailingEps": -0.47, "forwardEps": -0.49, "52WeekChange": -0.26666665, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 1.54, "targetHighPrice": 17.75, "targetLowPrice": 17.75, "targetMeanPrice": 17.75, "targetMedianPrice": 17.75, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1206285, "totalCashPerShare": 0.071, "totalDebt": 0, "quickRatio": 11.362, "currentRatio": 12.855, "returnOnAssets": -1.93299, "returnOnEquity": -3.55819, "freeCashflow": -3257019, "operatingCashflow": -6141097, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1691069400000, "postMarketChangePercent": 1.9480579, "postMarketPrice": 1.57, "postMarketChange": 0.03000009, "regularMarketChange": -0.11, "regularMarketDayRange": "1.53 - 1.65", "regularMarketChangePercent": -6.66667, "regularMarketPrice": 1.54, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "MIRA Pharmaceuticals, Inc.", "longName": "MIRA Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1754088815, "regularMarketTime": 1754078402, "exchange": "NCM", "messageBoardId": "finmb_1793899557", "ipoExpectedDate": "2023-08-03", "cryptoTradeable": false, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1477461, "fiftyTwoWeekLowChange": 0.80999994, "fiftyTwoWeekLowChangePercent": 1.109589, "fiftyTwoWeekRange": "0.73 - 2.7", "fiftyTwoWeekHighChange": -1.1600001, "fiftyTwoWeekHighChangePercent": -0.42962965, "fiftyTwoWeekChangePercent": -26.666664, "epsTrailingTwelveMonths": -0.47, "epsForward": -0.49, "epsCurrentYear": -0.385, "priceEpsCurrentYear": -4.0, "fiftyDayAverageChange": 0.14380002, "fiftyDayAverageChangePercent": 0.10299386, "twoHundredDayAverageChange": 0.29648495, "twoHundredDayAverageChangePercent": 0.2384249, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]